These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 36230796)

  • 1. Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer.
    Deng S; Vlatkovic T; Li M; Zhan T; Veldwijk MR; Herskind C
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
    Cui Y; Palii SS; Innes CL; Paules RS
    Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.
    Huang RX; Zhou PK
    Signal Transduct Target Ther; 2020 May; 5(1):60. PubMed ID: 32355263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer.
    Yang SH; Kuo TC; Wu H; Guo JC; Hsu C; Hsu CH; Tien YW; Yeh KH; Cheng AL; Kuo SH
    World J Gastroenterol; 2016 Aug; 22(32):7275-88. PubMed ID: 27621574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors.
    Gachechiladze M; Skarda J; Bouchalova K; Soltermann A; Joerger M
    Front Oncol; 2020; 10():581217. PubMed ID: 33224881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting ATR in cancer medicine.
    Sundar R; Brown J; Ingles Russo A; Yap TA
    Curr Probl Cancer; 2017; 41(4):302-315. PubMed ID: 28662958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer.
    Tomasini PP; Guecheva TN; Leguisamo NM; Péricart S; Brunac AC; Hoffmann JS; Saffi J
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Repair Inhibitors Potentiate Fractionated Radiotherapy More Than Single-Dose Radiotherapy in Breast Cancer Cells.
    Wong WK; Guerra Liberal FDC; McMahon SJ
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J; Tho LM; Xu N; Gillespie DA
    Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit.
    Palii SS; Cui Y; Innes CL; Paules RS
    Cell Cycle; 2013 Apr; 12(7):1105-18. PubMed ID: 23462183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.
    Chan Wah Hak CML; Rullan A; Patin EC; Pedersen M; Melcher AA; Harrington KJ
    Front Oncol; 2022; 12():971959. PubMed ID: 36106115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA-PKcs enhances radiosensitivity and increases the levels of ATM and ATR in NSCLC cells exposed to carbon ion irradiation.
    Yang L; Liu Y; Sun C; Yang X; Yang Z; Ran J; Zhang Q; Zhang H; Wang X; Wang X
    Oncol Lett; 2015 Nov; 10(5):2856-2864. PubMed ID: 26722253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shift in G
    Li F; Mladenov E; Dueva R; Stuschke M; Timmermann B; Iliakis G
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade.
    Wu X; Kang X; Zhang X; Xie W; Su Y; Liu X; Guo L; Guo E; Li F; Hu D; Qin X; Fu Y; Peng W; Jia J; Wang C
    Cancer Sci; 2021 Nov; 112(11):4444-4456. PubMed ID: 34382294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells.
    Takeuchi M; Tanikawa M; Nagasaka K; Oda K; Kawata Y; Oki S; Agapiti C; Sone K; Miyagawa Y; Hiraike H; Wada-Hiraike O; Kuramoto H; Ayabe T; Osuga Y; Fujii T
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31805725
    [No Abstract]   [Full Text] [Related]  

  • 16. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.
    Gatei M; Sloper K; Sorensen C; Syljuäsen R; Falck J; Hobson K; Savage K; Lukas J; Zhou BB; Bartek J; Khanna KK
    J Biol Chem; 2003 Apr; 278(17):14806-11. PubMed ID: 12588868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy.
    Manic G; Obrist F; Sistigu A; Vitale I
    Mol Cell Oncol; 2015; 2(4):e1012976. PubMed ID: 27308506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment.
    Li S; Wang L; Wang Y; Zhang C; Hong Z; Han Z
    J Hematol Oncol; 2022 Oct; 15(1):147. PubMed ID: 36253861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
    Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
    Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between DNA repair and autophagy in cancer therapy.
    Zhang D; Tang B; Xie X; Xiao YF; Yang SM; Zhang JW
    Cancer Biol Ther; 2015; 16(7):1005-13. PubMed ID: 25985143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.